PCCS 5th Annual Conference 2022 - Agenda 

Early bird welcome and address

Professor Ahmet Fuat
Enhancing the management of adults with symptomatic chronic heart failure

The promotional symposium session has been developed and funded by Boehringer Ingelheim and Lilly Alliance for UK Healthcare Professionals. Boehringer Ingelheim and Lilly Alliance products will be discussed at this meeting. Adverse event reporting and prescribing information is available at the meeting.

Speakers: Professor Ahmet Fuat and Delyth Rucarean

NP-GB-103106 I August 2022

Formal President's Opening Address

Dr Jim Moore
KEYNOTE ADDRESS

Chair: Dr Jim Moore

  • What is population health, why is it important and how do we deliver it in CVD prevention?

            Speaker: Dr Shahed Ahmad

SESSION 1: HYPERTENSION
Chair: Prof Terry McCormack
  • 09:50 - Why prioritise hypertension diagnosis and management?
            Speaker: Prof Neil Poulter
  • 10:10 - How do we deliver population health in hypertension?
            Speaker: Dr Hannah Morgan
  • 10:30 - Session Q&A
Refreshment break
Identifying and managing high risk lipid patients in the primary care setting

This is a promotional symposium intended for UK HCPs only, prepared and funded by Amgen

Speaker: Dr Kevin Fernando

SESSION 2: LIPIDS

Chair: Dr Peter Green

  • 11:40 - How are we performing in lipid management in England

            Jules Payne

  • 12:00 - How do we deliver population health in hyperlipidaemia?

            Mahmoud Khodadi

  • 12:20 - Session Q&A
Lunch break
Lunchtime Symposium
SESSION 3 ATRIAL FIBRILLATION
Chair: Trudie Lobban
  • 13:30 - Atrial fibrillation detect, protect and perfect across England

            Speaker: Helen Williams

  • 13:50 - Delivering predict, detect, protect and prevent in AF in primary care

            Speaker: Prof Ahmet Fuat

  • 14:10 - Session Q&A
Refreshment break
Afternoon symposium
SESSION 4: LIFESTYLE AND CARDIAC REHABILITATION

Chair: Dr Kathryn Carver

  • 15:20 - Why is cardiac rehabilitation important and how are we doing in delivery?

            Speaker: Prof Susan Dawkes

  • 15:40 - REACH-HF : Rehabilitation enablement in chronic heart failure - what can we learn?

            Speaker: Prof Rod Taylor 

  • 16:00 Session Q&A

Closing remarks
Chair’s opening


Dr Jim Moore

Professor Ahmet Fuat

Breakfast sponsored symposium
SESSION 5: HEART FAILURE AND HEART VALVE DISEASE

Chair: Professor Roy Gardner

  • 09:30 - SGLT2 inhibition in people with heart failure: what does the evidence tell us

            Speaker: Dr Jim Moore

  • 09:50 - Detection of valve disease in primary care

            Speaker: Dr Murad Khan

  • 10:10 - Session Q&A
Refreshment break
Late morning sponsored symposium
SESSION 6: CARDIO-RESPIRATORY SESSION

Chair: Carol Stonham

  • 11:20 - COPD and CVD - how managing them in tandem can improve outcomes 

            Speaker: Dr Katherine Hickman

  • 11:40 - The national breathlessness pathway

            Speaker: Prof Nick Linker

  • 12:00 - Session Q&A
Lunch break
A population health approach to lipid management: Implementation experience in England (a promotional symposium sponsored by Novartis)

This sponsorship is organised and funded by Novartis Pharmaceuticals UK Ltd. Prescribing information for any Novartis products will be disclosed at the event.

Chair: Dr Derek Connolly

Speakers: Amanda Waite and Barry Todd

SESSION 7: CKD AND PAD

Chair: Dr Kathryn Griffith

  • 13:10 - CKD and CVD - a deadly combination?

            Speaker: Dr Raj Thakkar

  • 13:30 - PAD recognition in primary care simplified

            Speaker to be confirmed

  • 13:50 - Session Q&A
Reducing CV events in high risk patients: A practical approach
Sponsorship of this symposium is initiated, developed and funded by © Amarin Pharmaceutical Ireland Limited.

Speakers: Dr Derek Connolly and Dr Waqas Tahir 

Closing remarks
PCCS AGM and plans for the future

agenda subject to change